<DOC>
	<DOCNO>NCT01233583</DOCNO>
	<brief_summary>The aim study understand therapy suppress effector cell promote regulatory T cell To test whether patient well response therapy longer psoriasis-free period develop high numerical ratio regulatory effector T-cells and/or regulatory cell able suppress effector .</brief_summary>
	<brief_title>Regulatory T-cells Psoriasis Patients Targets Therapy</brief_title>
	<detailed_description>This observational study effect different treatment option psorisis regulatory T-cells . Patients decision treat one follow therapy ( Dovobet , neotigason , narrow-band UVB anti TNF alpha therapy ) agree take part study select . Allocation different treatment patient part study . We enroll 40 patient moderate severe psoriasis age range 18 70. patient must treatment-free least 2 week topical application 4 week systemic treatment psoriasis . female child bear potential must reliable contraception . Children 18 year , patient 70 year , pregnant lactating patient immunosuppressed patient exclude study . Blood tissue sample take treatment . We also invite 10 patient receive ellipse excision naevi , know psoriasis , provide control sample distal skin beyond margin require demonstrate complete removal control donation blood .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>• Male female patient age range 18 70 diagnosed moderate severe psoriasis . Patients must treatment free least 2 week topical application 4 week systemic treatment psoriasis . Women child bear potential must reliable contraception . Patients decision treat one follow therapy already make base normal clinical care : Dovobet Neotigason Narrowband UVB Etanercept Adalimumab Infliximab 10 normal control • Children 18 year patient 70 year . Pregnant lactating patient . Patients know immunosuppressive disease ( e.g . HIV ) immunosuppressive therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Regulatory T-cells , psoriasis , IL-10 .</keyword>
</DOC>